Board of Director of the Company has inter-alia considered and approved a Resolution Passed by Circulation on 28th July, 2026 and the final majority vote was received by 08:00 PM decided ....

A C C R E D I T E D ISO/IEC 17021 CERTIFICATION BODY Date: July 29, 2026 To, To, Bombay Stock Exchange Limited National Stock Exchange Limited 25th Floor, PJ Towers Exchange Plaza, C-1, Block G Dalal Street, Bandra Kurla Complex, Bandra (E) Mumbai – 400 001 Mumbai – 400 051 Scrip Code: 524654 Symbol: NATCAPSUQ Dear Sir/Madam, Sub: Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 – Dilution of equity shareholding in Subsidiary Company due to non-participation in Rights Issue. Pursuant to Regulation 30 read with Part A of Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the Company has inter-alia considered and approved a Resolution passed by Circulation on 28th July 2026 and the final majority vote was received by 08:00 PM deciding not to subscribe to the Rights Issue offered by its subsidiary company, Natural Biogenex Private Limited ("Subsidiary") Consequent to the non-participation by the Company during the subscription period open from 14th July 2026 to 28th July 2026 and the subsequent allotment of shares by the Subsidiary to other investors/applicants, the equity stake of the Company in the said Subsidiary will face a dilution of 2.18% Yours Faithfully, For Natural Capsules Limited Akshay Dutta Company Secretary and Compliance Officer M.No. A80481 Date: July 29, 2026 Place: Bangalore A C C R E D I T E D ISO/IEC 17021 CERTIFICATION BODY The details required under SEBI Circular No. SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated July 13, 2023, are as under: Particulars Details 1 Name of the subsidiary Natural Biogenex Private Limited Turnover: Rs. 13.43 Crore Turnovers / Net Worth / Total Income of the 2 Net Worth: Rs. 81.24 Crore subsidiary (for last financial year) Profit/Loss: Rs - 43.30 crore Whether the transaction would fall within 3 (The non-participation itself is not a transaction with a related related party transaction(s)? party, but the dilution happens due to third-party allotment). Shareholding of the Parent Company prior 4 1,99,99,996 Equity Shares, 68.96% of the paid-up capital to the Rights Issue dilution Shareholding of the Parent Company post 1,99,99,996 Equity Shares, 66.78 % of the revised paid-up completion of the Rights Issue capital 6 Status of the target entity post this dilution The entity remains a Subsidiary of the Company. Brief reasons for non-participation in the Non-participation is based on strategic allocation of the funds on Rights Issue other business matters. We request you to kindly take the above information on your record. For Natural Capsules Limited Akshay Dutta Company Secretary and Compliance Officer M.No. A80481